Operating the first remotely accessible biocomputing research platform using living human brain organoids on multi-electrode arrays as computational substrates.
Funding, launches and regulatory moves across the neurotech startup map, delivered every two weeks.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Seed
MODALITY
MEA
FORM FACTOR
Other
INTERFACE DEPTH
Ex vivo
INDICATION
Research
TARGET USER
Researchers
REGULATORY STAGE
Research only
FinalSpark is the most operationally distinctive biocomputing company, having built the only remotely accessible organoid computing platform with a subscriber base across ten universities. Its differentiation lies in infrastructure democratization rather than proprietary science, making it closer to cloud-lab infrastructure for wetware research than a product company with defined clinical or commercial endpoints.
.svg)
